Remdesivir plus dexamethasone vs dexamethasone alone reduces the risk of mortality among patients hospitalized with COVID-19.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

It takes a cracked mindset to name a cracked pot with no scientific training to head the agency that oversees 11 agencies tasked with protecting Americans’ health. They include the Food and Drug Admin ...

It takes a cracked mindset to name a cracked pot with no scientific training to head the agency that oversees 11 agencies ...

It takes a cracked mindset to name a cracked pot with no scientific training to head the agency that oversees 11 agencies ...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI ), a commercial-stage Pharmaceutical company pioneering novel cancer therapies, today announced abstracts detailing selinexor data have been selected to be ...

What a card! When Trump came down with COVID, there was no "running wild" with his care. He was airlifted to Walter Reed Hospital, where he received first-class treatment informed by the best science: ...

Dexamethasone treatment was not linked to improved survival nor clinical outcomes among patients with diabetes and COVID-19 infection. Dexamethasone treatment is not associated with improved survival ...

More recent studies, however, have looked at the viability of corticosteroids for treating COVID-19 and their potential for reducing the duration and severity of the disease. A study reported in ...

According to the CDC, mild to moderate cases of COVID-19 remain infectious no longer than 10 days after symptom onset. If you test negative on a rapid antigen test, make sure to get tested again a few ...